<DOC>
	<DOCNO>NCT01721954</DOCNO>
	<brief_summary>This study randomize , multi-center study compare efficacy safety selective internal radiation therapy ( SIRT ) use SIR-Spheres microspheres plus standard chemotherapy regimen FOLFOX6m versus FOLFOX6m alone first-line therapy patient non-resectable liver metastasis primary colorectal carcinoma . Treatment biologic agent bevacizumab , part standard care participate institution , allow within study discretion Investigator .</brief_summary>
	<brief_title>FOLFOX6m Plus SIR-Spheres Microspheres v FOLFOX6m Alone Patients With Liver Mets From Primary Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Age 18 year old Willing able provide write informed consent Unequivocal measurable CT evidence liver metastases treatable surgical resection local ablation Limited extrahepatic metastasis lung and/or lymph node permit ( Lung : 5 lesion total , &lt; 1 cm , 1 single lesion 1.7 cm ; Lymph nodules one single anatomic area ( pelvis , abdomen chest ) : number , &lt; 2 cm ) All image evidence use part screen process must within 28 day Suitable either treatment regimen WHO performance status 01 Adequate hematological , renal hepatic function Life expectancy least 3 month without active treatment Evidence ascites , cirrhosis , portal hypertension , main portal venous involvement thrombosis determine clinical radiologic assessment Previous radiotherapy deliver liver Nonmalignant disease would render patient unsuitable treatment accord protocol Peripheral neuropathy &gt; grade 2 ( NCICTC ) Doselimiting toxicity associate previous adjuvant 5FU oxaliplatin chemotherapy Prior nonadjuvant chemotherapy malignancy . Adjuvant chemotherapy colorectal cancer permit provide complete 6 month entry study Pregnant breast feeding Concurrent prior history cancer adequately treat nonmelanoma skin cancer carcinoma situ cervix Allergy contrast medium would preclude angiography hepatic artery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>colon</keyword>
	<keyword>rectum</keyword>
	<keyword>metastatic colorectal cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>